Loading…
Loading the latest PSX data…
CWHC vs GLAXO vs ABOT
Crestwell Healthcare Limited (CWHC), GlaxoSmithKline Pakistan Limited (GLAXO), Abbott Laboratories (Pakistan) Limited (ABOT): performance, valuation, growth, risk and danioPSX score, side by side.
Stock 1
Stock 2
Stock 3
Add a stock
Price performance
Not enough shared daily history to compare.
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | CWHCPharmaceuticals | GLAXOPharmaceuticals | ABOTPharmaceuticals |
|---|---|---|---|
| danioPSX score | – | 83 | 70 |
| Price and size | |||
| Price | Rs 21.45 | Rs 306.97 | Rs 920.00 |
| Today | +0.75% | −0.73% | −0.83% |
| Market cap | Rs 1.5bn | Rs 97.8bn | Rs 90.1bn |
| Traded per day | Rs 0 | Rs 23m | Rs 8m |
| Valuation and dividends | |||
| P/E | – | 9.4 | 10.5 |
| Dividend yield | – | 5.1% | 4.1% |
| EPS (last year) | – | Rs 31.48 | Rs 81.37 |
| Business | |||
| EPS growth | – | +53.4% | +52.2% |
| Sales growth | – | +7.7% | +10.6% |
| Net margin | – | 15.2% | 10.6% |
| Returns | |||
| 1 month | – | −2.0% | +0.3% |
| 3 months | – | −9.8% | +1.0% |
| 1 year | – | −26.3% | −24.2% |
| vs KSE-100, 1 year | – | -23.6 pts | -21.5 pts |
| Trend and risk | |||
| 52-week position | – | 10% | 24% |
| RSI 14 | – | 40 | 49 |
| RS rank | – | 24 | 47 |
| Volatility | – | 34% | 30% |
| Beta | – | 1.04 | 0.77 |
| danioPSX score | |||
| Value | – | 71 | 63 |
| Quality | – | 80 | 73 |
| Dividend | – | 59 | 29 |
| Momentum | – | 24 | 45 |
| Safety | – | 76 | 70 |
| Shariah-compliant | Yes | Yes | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener